Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Roberta W Scherer"'
Publikováno v:
Journal of Human Reproductive Sciences, Vol 8, Iss 1, Pp 30-36 (2015)
Aim: To review the experience on depot-dose, and daily low-dose gonadotropin releasing hormone agonist (GnRHa) long protocols and identify prognostic factors. Setting And Design: A chart review was conducted on 2106 depot and 1299 daily low-dose cycl
Externí odkaz:
https://doaj.org/article/558b7116e59f4b20a8f4f1982d968efd
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0130619 (2015)
BACKGROUND:Including results from unpublished randomized controlled trials (RCTs) in a systematic review may ameliorate the effect of publication bias in systematic review results. Unpublished RCTs are sometimes described in abstracts presented at co
Externí odkaz:
https://doaj.org/article/a6e3ec1c7d31417d92177af9b316ad18
Autor:
Christine Schmucker, Lisa K Schell, Susan Portalupi, Patrick Oeller, Laura Cabrera, Dirk Bassler, Guido Schwarzer, Roberta W Scherer, Gerd Antes, Erik von Elm, Joerg J Meerpohl, OPEN consortium
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e114023 (2014)
BACKGROUND: The synthesis of published research in systematic reviews is essential when providing evidence to inform clinical and health policy decision-making. However, the validity of systematic reviews is threatened if journal publications represe
Externí odkaz:
https://doaj.org/article/4ff7cc27b4694c0aa1c267091c4712e7
Publikováno v:
PLoS ONE, Vol 7, Iss 9, p e44183 (2012)
To reduce publication bias, systematic reviewers are advised to search conference abstracts to identify randomized controlled trials (RCTs) conducted in humans and not published in full. We assessed the information provided by authors to aid identifi
Externí odkaz:
https://doaj.org/article/955415cf8aa240628df96881c3a3f8a5
Autor:
Krista L. Lanctôt, Clara Chen, Ethan Mah, Alex Kiss, Abby Li, Dave Shade, Roberta W. Scherer, Danielle Vieira, Hamadou Coulibaly, Paul B. Rosenberg, Alan J. Lerner, Prasad R. Padala, Olga Brawman-Mintzer, Christopher H. van Dyck, Anton P. Porsteinsson, Suzanne Craft, Allan Levey, William J. Burke, Jacobo Mintzer, Nathan Herrmann
Publikováno v:
International Psychogeriatrics. :1-9
Background: This paper used data from the Apathy in Dementia Methylphenidate Trial 2 (NCT02346201) to conduct a planned cost consequence analysis to investigate whether treatment of apathy with methylphenidate is economically attractive. Methods: A t
Autor:
Daniela R. Junqueira, Liliane Zorzela, Susan Golder, Yoon Loke, Joel J. Gagnier, Steven A. Julious, Tianjing Li, Evan Mayo-Wilson, Ba Pham, Rachel Phillips, Pasqualina Santaguida, Roberta W. Scherer, Peter C. Gøtzsche, David Moher, John P.A. Ioannidis, Sunita Vohra, Stephen Evans, Ann Fonfa, Thomas A. Lang, Elizabeth Loder, Laura Weeks
Randomized controlled trials remain the reference standard for healthcare research on effects of interventions, and the need to report both benefits and harms is essential. The Consolidated Standards of Reporting Trials (the main CONSORT) statement i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de97f80993288b9a4a9125366874f136
http://hdl.handle.net/10044/1/104238
http://hdl.handle.net/10044/1/104238
Autor:
Fasika A Woreta, Kristina B Lindsley, Almutez Gharaibeh, Sueko M Ng, Roberta W Scherer, Morton F Goldberg
Publikováno v:
Cochrane Database of Systematic Reviews. 2023
Publikováno v:
Res Eval
Background The National Institutes of Health (NIH) announced a revised, expanded definition of ‘clinical trial’ in 2014 to improve trial identification and administrative compliance. Some stakeholders voiced concerns that the policy added adminis
Publikováno v:
J Speech Lang Hear Res
Purpose: Tinnitus retraining therapy (TRT) has been widely used for 30 years, but its efficacy and the component contributions from counseling and sound therapy remain controversial. The purpose of this secondary analysis from the Tinnitus Retraining
Publikováno v:
Am J Audiol
Purpose This clinical focus article is a companion to the work of Erdman et al. (2019), in which we described the rationale, development, and implementation of the standard-of-care protocol used in the Tinnitus Retraining Therapy Trial (TRTT), a mult